Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Chovatiya, Raj [1 ]
Wollenberg, Andreas [2 ,3 ]
Ribero, Simone [4 ]
Saeki, Hidehisa [5 ]
Oland, Christian B. [6 ]
Steffensen, Louise A. [6 ,9 ]
Tindberg, Ann-Marie [6 ]
Thyssen, Jacob P. [6 ,7 ]
Blauvelt, Andrew [8 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Univ Hosp Augsburg, Augsburg, Germany
[3] Ludwig Maximilian Univ Munich, Munich, Germany
[4] Univ Turin, Turin, Italy
[5] Nippon Med Sch, Tokyo, Japan
[6] LEO Pharm AS, Ballerup, Denmark
[7] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[8] Oregon Med Res Ctr, Portland, OR USA
[9] Argenx SE, Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; tralokinumab; IL-13; head and neck;
D O I：
10.1093/bjd/ljae266.030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
651
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Bewley, Anthony
    Hong, H. Chih-ho
    Silvestre, Juan Francisco
    Peris, Ketty
    Wollenberg, Andreas
    Ivens, Ulla
    Soehoel, Anders
    Steffensen, Louise Abildgaard
    Tindberg, Ann-Marie
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (03) : 410 - 419
  • [32] Sleep improvement with dupilumab in adults with moderate-to-severe atopic dermatitis: Results of the DUPISTAD study
    Merola, J.
    Chiou, A.
    Foley, P.
    Ardeleanu, M.
    Wu, J.
    Ozturk, Z. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [33] Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
    Lyakhovitsky, A.
    Barzilai, A.
    Heyman, R.
    Baum, S.
    Amichai, B.
    Solomon, M.
    Shpiro, D.
    Trau, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (01) : 43 - 49
  • [34] Validation of the pruritus and symptoms assessment for atopic dermatitis in adults with moderate-to-severe atopic dermatitis
    Lebwohl, M. G.
    Simpson, E. L.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Gooderham, M. J.
    Wollenberg, A.
    Hall, R.
    Gater, A.
    Wells, J. R.
    Papacharalambous, J.
    Hsu, M. A.
    Tallman, A. M.
    Peeva, E.
    Zhang, W.
    Chen, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E44 - E44
  • [35] Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
    Ameen, Mahreen
    Alhusaye, Raed
    Brandi, Henrik
    Bogelund, Mette
    Jensen, Henrik H.
    Reitzel, Signe B.
    Thyssen, Jacob P.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [36] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
  • [37] Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan
    Hagino, Teppei
    Onda, Marina
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (05) : 525 - 532
  • [38] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [39] RAPID AND SUSTAINED IMPROVEMENT IN SLEEP QUALITY, ANXIETY, AND DEPRESSION IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS WITH DUPILUMAB TREATMENT
    Merola, Joseph F.
    Chiou, Albert S.
    During, Emmanuel
    Foley, Peter
    Ardeleanu, Marius
    Wu, Jiangming
    Ozturk, Zafer E.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 44 - 45
  • [40] Progressive and sustained improvements in the extent and severity of atopic dermatitis with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis
    Alexis, A. F.
    Zirwas, M.
    Pinter, A.
    Adam, D. N.
    Chiricozzi, A.
    Pink, A. E.
    Mark, T.
    Tindberg, A. M.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E82 - E83
12345